This is an open access article distributed under the terms of the Creative Commons Attribution License (
In this study, we formulate a computational reaction model following a chemical kinetic theory approach to predict the binding rate constant for the siRNA-RISC complex formation reaction. The model allowed us to study the potency difference between 2-nt 3' overhangs against blunt-ended siRNA molecules in an RNA interference (RNAi) system. The rate constant predicted by this model was fed into a stochastic simulation of the RNAi system (using the Gillespie stochastic simulator) to study the overall potency effect. We observed that the stochasticity in the transcription/translation machinery has no observable effects in the RNAi pathway. Sustained gene silencing using siRNAs can be achieved only if there is a way to replenish the dsRNA molecules in the cell. Initial findings show about 1.5 times more blunt-ended molecules will be required to keep the mRNA at the same reduced level compared to the 2-nt overhang siRNAs. However, the mRNA levels jump back to saturation after a longer time when blunt-ended siRNAs are used. We found that the siRNA-RISC complex formation reaction rate was 2 times slower when blunt-ended molecules were used pointing to the fact that the presence of the 2-nt overhangs has a greater effect on the reaction in which the bound RISC complex cleaves the mRNA.
RNA interference (RNAi) refers to a post-transcriptional gene silencing mechanism with potential therapeutic application for the treatment of various diseases including cancer, viral infections, and neurodegenerative disorders [
An important consideration towards selecting an effective siRNA-based gene silencing tool is the duration of effect and efficacy of a candidate molecule. Extensive studies determining the intensity of gene silencing mediated by siRNA were reported in Ref. [
Upon introduction into a cell, a siRNA molecule will be diluted over time due to its degradation and cellular proliferation resulting in a decrease in its effective concentration. Consequently, the expression level of the target gene will return to a normal level after the gene silencing period, dependent upon the number of siRNA molecules actually entering the cell. To use siRNA for silencing target gene expression, it is important to understand how long the target mRNA or protein is suppressed by the siRNA. Maximal inhibitory efficiency of siRNA, a parameter that has frequently been used to express the potency of each siRNA, should be discussed in context with the duration or persistence of its effect.
Figure
In this study, we use computational modeling to investigate the potency effects of the widely used 21-nt siRNAs with 2-nt 3' overhangs as compared to blunt-ended siRNA molecules to assess the effectiveness of the latter as an alternative structural entity. We have developed a simple systems biology simulation to quantitatively assess both the intensity and duration of gene silencing by siRNA. The stochastic simulation framework presented here allows us to predict some quantitative and qualitative aspects of the RNAi system for the two different types of siRNAs.
The reaction model was built to investigate the potency difference between 2-nt 3' overhangs and blunt-ended siRNA molecules. We identified that the siRNA-RISC complex formation reaction rate was altered due to the different siRNA molecular structures. We assume that once the bound RISC complex is formed, it will cleave the mRNA with the same rate irrespective of the presence of the overhangs on the siRNA. Findings in Ref [
Hence, our first contribution is a chemical kinetic theory based analytical model for measuring the rate constant of the siRNA-RISC complex formation reaction. The two different rate constants predicted by this model for the different siRNA structures were then fed into a stochastic simulation (using the widely used Gillespie stochastic simulator [
Consider the elementary reaction with three types of molecules siRNA, RISC and the siRNA-RISC complex:
We divide the reaction event into two independent micro-events as follows; 1) Random collisions between the reactants; this allows us to compute the probability of collision (pc) between the reactant molecules. 2) A reaction will occur only when the kinetic energy of the colliding reactant exceeds the activation energy requirement for the reaction. Using these two events, allows us to compute the probability of reaction (pr).
The total probability for reaction after a collision is hence the joint probability of these two events. To model this reaction analytically in the time domain, we first assume that the siRNA molecules enter the cell one at a time. Note that siRNAs are typically delivered via transfection thereby introducing a bolus of molecules into the cell. Thus, we need to consider the effective number of siRNAs in the cell while computing the binding rate. We will show how the computations change while we consider a certain concentration of siRNA molecules for deriving the overall binding rate subsequently in this section. We also assume that the cell contains a fixed number, n2, of RISC molecules. Note that while modeling the reaction, it is not necessary to consider the fact that the siRNAs or RISC complexes can also take part in other reactions with other reactants or can degrade independently. The time domain model is based solely on the current instance of these two reactants in the cell as the time taken to complete this reaction will generally be less in comparison to the time taken to degrade a siRNA or a RISC molecule. The idea here is to discretize this reaction from other competing reactions that can change the concentrations of the siRNA/RISC molecules. Though this approximation might lead to less accurate predictions of the binding rate for this reaction, we can still consider the effects of such competing reactions by the system simulation of the RNAi pathway (as shown later).
We follow the principles of collision theory for hard spheres [
To discretize the system, we consider the dynamics of this process within a small time Δt. We assume that the temporal reaction process is an independent sequence of events separated by Δt. In time Δt, the siRNA molecule sweeps out a volume ΔV given by: ΔV =
Now, the probability of a siRNA molecule being present in the collision volume ΔV is psiRNA = 1. This is because we have already assumed that one siRNA molecule entered the cell creating a collision volume of ΔV.
Probability of at least one molecule of RISC being present in an arbitrary uniformly distributed ΔV in V is pRISC = ΔV.n2/V, where V denotes the cell volume. Ideally V should be the volume of the cytoplasm, which can be approximated by the entire cell volume. The probability that a siRNA molecule collides with a RISC molecule in Δt is given by:
Thus we have a stochastic sequence of events characterized by the probability of collision, and it is important to determine whether the collision will create the reaction. To complete the reaction, the molecules have to bind to each other. Different types of bonds (ionic, covalent, hydrogen etc.) require different activation energies for binding. We next assume that the colliding molecules must cross an energy threshold, defined by the free energy EAct, to provide the energy to react. Also, we assume that only the kinetic energy directed along the line of centers of the two reacting molecules contribute to the reaction as the effects of other forces (e.g. coulomb force) can been captured by the velocity distribution of the siRNA molecules in the cell.
These two assumptions define the probability of another independent event: successful reaction after collision denoted by pr. The kinetic energy of approach of a siRNA towards the RISC molecule with relative velocity U12 is E = m12.U122/2, where m12 = m1.m2/(m1+ m2) = the reduced mass, m1 = mass (in gm) of a siRNA molecule and m2 = mass (in gm) of a RISC molecule. We also assume that as E increases above EAct, the number of collisions that result in reaction also increases linearly. Thus the probability for a reaction to occur, pr, is given by:
and hence, the joint probability, p, for collision and reaction is given by:
Until now we were working with a fixed relative velocity U12 for the siRNA molecules. The velocity distribution of the macromolecules inside a cell capturing the effects of the different forces as obtained from Molecular Dynamic Simulation is generally found to be comparable to the Maxwell-Boltzmann distribution [
where kb = Boltzmann's constant = 1.381 × 10-23 kg-m2/s2/K/molecule and T is the absolute temperature at which the reaction occurs. Replacing m with the reduced mass m12 of the molecules, we get,
The term on the left hand side of the above equation denotes the fraction of siRNA molecules with relative velocities between U and (U+dU). Summing up the collisions for the siRNA molecules for all velocities we get the probability of reaction, p, as a function of temperature only as follows:
Now, recalling E = m12.U122/2, i.e., dE = m12U12dU and substituting into the expression for f(U, T)dU, we get:
Thus we get:
To consider a certain concentration of siRNA molecules, we assume that n1 number of siRNA molecules are present in the cell. This will increase the probability of a successful reaction by a factor of n1, and hence we have:
We discretize the temporal reaction process as a Bernoulli trial process. Next we compute the average time taken to complete the reaction with this probability. Let us assume that the molecule composition does not change during the reaction time. This is valid due to the very short time for reaction compared to the time taken for a potential change in the reaction environment for the associated molecules. The molecules try to react through repeated collisions. If the first collision fails to produce a reaction, they collide again after Δt time units and so on. We can interpret p as the probability of a successful reaction in time Δt. Thus the average time of reaction, Tavg, can be approximated by summing up the times taken for a successful reaction by the first collision, or that by the second collision and so on. Thus we get:
Similarly, the corresponding second moment, T2ndmoment, can be formalized by
This gives us the first and second moments of the reaction time, which is considered to be a random variable. The binding rate for this reaction can be easily estimated as 1/Tavg although the reaction is essentially stochastic. Note that, the expression for the binding rate from our model is exactly the same as that derived by chemical kinetic modeling of reaction rates. However, our model allows us to study the inherent stochasticity of the reaction considered.
The above model was used to study the binding rate of siRNA molecules. Note that the model requires an estimate of the activation energy for the siRNA-RISC complex formation reaction. However, it is very difficult to experimentally measure the activation energy required for a reaction. The activation energy is generally derived from the heat of reaction (-ΔH0) by using the Polyani equation [
We observed that the siRNA-RISC reaction occurs when the siRNA duplex breaks down into two single-stranded molecules one of which enters the reaction (the antisense strand), while the other (the sense strand) disintegrates. The antisense strand enters into a docking reaction with the RISC complex. Thus, we can rewrite the siRNA-RISC complex formation reaction in the following form:
Note that we treat the double stranded siRNA as a complex between the sense (siRNAsense) and antisense (siRNAantisense) strands. Referring to the reaction model discussed above, the two colliding macromolecules will be the siRNAsense siRNAantisense and RISC complexes. This also motivates the use of the Polyani equation for measuring the activation energy, which particularly works well for the following family of reactions:
Spectometric measurements on the thermodynamics of double-helix formation reported in Refs. [
Hence, to measure the heat of reaction, we can use the heat of reaction required to dissociate the siRNA duplex. Note that, the second part of the reaction being essentially a docking reaction does not require any activation energy [
where, Edissociation is the energy required for the dissociation of the double-stranded siRNAs while Eelectrostatic and Esolvationcorrespond to the electrostatic and solvation energy requirements for the docking reaction.
The Polyani equation for exothermic reactions is used for estimating Edissociation from the Gibb's free energy measurements as follows:
A recent study on siRNA duplex stability [
Ref. [
Simple RNAi system equations
| Reaction | Rate Constant | |
| 1 | mRNA + siRNA -> gRNA | 0.008 hr-1 |
| 2 | dsRNA -> 10*siRNA | 2.0 hr-1 |
| 3 | mRNA -> dsRNA | 0.002 hr-1 |
| 4 | 160.0 hr-1 | |
| 5 | siRNA -> |
2.0 hr-1 |
| 6 | mRNA -> |
0.14 hr-1 |
| 7 | gRNA -> |
2.8 hr-1 |
With the above findings, we estimated the Gibb's free energy change for dissociating the 21-nt siRNA duplexes of the following two types: 1) 21-nt siRNAs with 2-nt overhangs and 2) 21-nt blunt-ended siRNAs. The corresponding ΔG370 estimates are -21.2 kcal/mol and -20.4 kcal/mol respectively. The experimental setup is explained in the Appendix. This results in a 2-fold difference in the rate constant using these two types of molecules with the blunt-ended ones having a lower rate constant than their 2-nt overhang counterparts (i.e. Tavgblunt-end/Tavg2-nt = 2, where Tavgblunt-endand Tavg2-nt are the average reaction times for blunt-ended and 2-nt siRNAs respectively). Again we have assumed that the mass and radii of these two types of siRNAs are comparable and only the activation energy parameter from our reaction model makes the rate constant different. Also, note that the cell volume parameter cancels out as we only need to compute the ratio (Tavgblunt-end/Tavg2-nt) and not the actual rate constants. Similarly, we have assumed that Eelectrostatic and Esolvation will be the comparable for the two types of siRNAs and will cancel out as we compute Tavgblunt-end/Tavg2-nt. Note that Eelectrostatic can be computed using the siRNA 3-d structures using standard software like Delphi [
Blunt-end and 2-nt 3' overhang siRNA's were reconstituted in buffer at 20
We primarily employed Dizzy [
Table
Initial conditions
| Reactant | Number of molecules |
| mRNA | 1000 |
| siRNA | 0 |
| dsRNA | 200 |
| gRNA | 0 |
Next we consider the transcription/translation machinery to study the potential effects of stochastic mRNA production on the RNAi system [
RNAi system with transcription/translation machinery
| Reaction Number | Reaction | Rate Constant | Remarks |
| 1 | mRNA + siRNA -> gRNA | 0.008 hr-1 | |
| 2 | dsRNA -> 10*siRNA | 2.0 hr-1 | |
| 3 | mRNA -> dsRNA | 0.002 hr-1 | |
| 4 | siRNA -> |
2.0 hr-1 | |
| 5 | mRNA -> |
18 hr-1 | |
| 6 | gRNA -> |
2.8 hr-1 | |
| 7 | O + R -> O_R | 12.0 hr-1 | Regulatory molecule R binds to the operator region O to form the bound complex O_R |
| 8 | O_R -> O + R | 0.24 hr-1 | O_R dissociates into free R and O |
| 9 | P + RNAP -> P_RNAPC | 1.2 hr-1 | RNAP binds to promoter region P forming closed complex P_RNAPC |
| 10 | P_RNAPC -> P + RNAP | 0.06 hr-1 | P_RNAPC dissociates into free RNAP and P |
| 11 | P_RNAPC -> P_RNAPO | 48 hr-1 | Isomerization of closed to open complex (P_RNAPO) |
| 12 | P_RNAPO -> TrRNAP + mRNA + P | 54 hr-1 | RNAP clears promoter region and mRNA chain synthesis starts. TrRNAP denotes transcribing RNA polymerase. |
| 13 | TrRNAP -> RNAP | 4.8 hr-1 | RNAP completes transcription and is released from DNA. |
| 14 | mRNA + Ribosome -> RibRBS | 0.6 hr-1 | Ribosome binds to mRNA forming bound complex RibRBS |
| 15 | RibRBS -> mRNA+ Ribosome | 0.06 hr-1 | Ribosome dissociation from RibRBS |
| 16 | RibRBS -> EIRib + mRNA | 18 hr-1 | Ribosome EIRib initiates translation of mRNA chain |
| 17 | EIRib -> protein | 48 hr-1 | Protein synthesis by transcribing ribosome |
| 18 | protein -> |
0.18 hr-1 | Protein product degradation |
Initial Conditions for the combined RNAi system
| Reactant | Number of molecules |
| mRNA | 1000 |
| siRNA | 0 |
| dsRNA | 200 |
| gRNA | 0 |
| R | 20 |
| O | 1 |
| O_R | 0 |
| P | 200 |
| RNAP | 400 |
| P_RNAPC | 0 |
| P_RNAPO | 0 |
| TrRNAP | 0 |
| Ribosome | 350 |
| RibRBS | 0 |
| EIRib | 0 |
| protein | 0 |
Figures
Next consider the effects of the RDR mechanism of replenishing the dsRNAs in the cell. Using the simple RNAi system (of Table
Additional reactions from Table 1 to consider the RDR mechanism
| Reaction Number | Additional Reactions from Table 2 | High Amplification | Low Amplification |
| 8 | gRNA -> dsRNA | 0.4 hr-1 | 0.02 hr-1 |
| 9 | mRNA + siRNA -> dsRNA | 0.002 hr-1 | 0.0002 hr-1 |
There is a slight difference in the mRNA levels with the 2-nt overhang siRNAs fairing a little better than their blunt-ended counterparts. However, we can get a relative quantification of the number of dsRNA molecules required to be inserted into the cell for two types of siRNAs considered to keep the mRNAs down at the same level. This will require more real-life initial concentration values for the other components of the RNAi system and also a model to predict the average number of dsRNA molecules that actually enter a single cell depending on the dosage amount and intervals. Our model provides a simulation framework that will help us study the gene silencing duration using siRNAs in the future.
We have computed the time taken to complete the reaction. The underlying assumption is that reactant collisions occur with some probability and once a collision of sufficient energy occurs, a reaction takes place instantaneously. Hence, we assume that there is no time delay to form an activated complex. If there is some time delay associated with initiation and completion of the reaction, the probability evolution becomes more complicated [
The Maxwell-Boltzmann distribution gives a good estimate of molecular velocities where we have spatial homogeneity and is widely used in practice. Molecular dynamic (MD) simulation measurements during protein reactions show that the velocity distribution of proteins in the cytoplasm closely matched the Maxwell-Boltzmann distribution [
The activation energy has been measured for many reactions and we need an estimate of this parameter to be able to predict the nature of the reaction time. We used the Polyani equation to compute Edissociation for the reaction by measuring the Gibb's free energy change to dissociate a siRNA duplex. As discussed before, this approximation can give us a relative difference in the reaction rates for the two types of siRNAs used in our study, but will fail to give us a direct quantification of the actual reaction rates (which will also require estimates of Eelectrostatic, Esolvation, mass, radii etc. for the siRNAs). We are exploring ways to measure the actual heat of reaction for the entire siRNA-RISC complex formation reaction and the other parameters to make the model predictions more accurate.
We did not consider the reverse reaction conditions in our model because we assumed the siRNA-RISC complex formation reaction as non-reversible. However, the Gillespie stochastic simulation framework allows us to incorporate reversible reactions if we know the forward and backward reaction rates [
In addition, there is increasing evidence of sub-compartmental (i.e., intra-compartmental localization) in cells, so local neighborhoods of reactions will have higher apparent concentrations than simply the number of molecules divided by the size of the compartment. However, this would require more in depth modeling of the different molecular concentrations inside the cell that reduces the scalability of the stochastic simulation framework. Indeed, the Gillespie simulator fails to address this issue as it requires different rate constants for specific neighborhoods of the reaction type. Nevertheless, our model can be easily extended to incorporate such reaction neighborhoods by limiting the movement of the reactant molecules inside a reaction space while computing the probability. However, the applicability of the Maxwell-Boltzmann velocity distribution in the neighborhood requires further research.
A related concern with this simulation model is the recent finding that RISC and other enzymes involved in RNA degradation tend to localize to discrete cytoplasmic foci known as P-bodies [
Many researchers today employ synthetic 21 mer RNA duplexes as their RNAi reagents, which mimic the natural siRNAs that result from Dicer processing of dsRNAs. An alternative approach is to use synthetic RNA duplexes that are greater than 21 mer length which are substrates for Dicer. These duplexes are typically 27-nt long and are processed by Dicer into 21 mer siRNAs. It has been reported that synthetic Dicer-substrate RNAs can have significantly increased potency (~100-fold) when compared with 21 mer duplexes [
More recent works targeted additional sites in other genes, to find examples where the longer RNAs had greater potency, the same potency, and lower potency than 21 mers at the same site. This wide variation in performance was primarily attributed to the differences in dicing patterns: sometimes Dicer processing resulted in a "good" 21 mer while other times it resulted in a "bad" 21 mer (Ref [
In this work, we have not studied the effects on potency while using synthetic 27 mers instead of the dsRNAs. This will require the ratios of the "good" and "bad" 21 mers that are diced from the 27 mers entering the cell as well as a similar thermodynamic stability study of these 21 mers to study their effects on the rate constant estimates.
The RNAi system simulation framework developed here presents some qualitative and quantitative results on the RNAi pathway. The simulation also explores the potency effects of the two types of siRNAs considered. We primarily focused on identifying the most important components of the system that play a role in identifying the potency effects. This framework can be extended to predict very important features of the RNAi pathway including the duration of gene silencing for the different siRNA molecules. This will require models to study the effective rate of dsRNA entry into the cell depending on the amount of dosage and dosage intervals. We plan to study these important aspects of the RNAi system, once we build more fidelity on this simulation framework.
The proposed model computes the reaction time for the siRNA-RISC complex formation reaction as a stochastic variable that appropriately reflects the cell environment. The concept of the model is to transform the reaction process from a continuous deterministic process to a discrete random one. The model allows the transformation of biological reactions to the stochastic domain and makes it suitable for a stochastic simulation of the RNAi system. The average reaction time estimated from this method is exactly the same as the reaction rate estimates of kinetic modeling. In addition, we are able to estimate the first two moments of the reaction time to capture the stochastic nature of the reaction. The reaction model was used to study the difference in binding rate for the 2-nt 3' overhang siRNAs and the blunt-ended siRNAs, and we found that the reaction rate is predicted to double when 2-nt 3' overhang siRNAs are used. We next built an RNAi stochastic system simulation using the Gillespie simulator to study the overall potency effects of the two types of siRNAs. Initial findings suggest that about 1.5 times more blunt-ended siRNAs are required to keep down the mRNA at the same level as using 2-nt 3' overhang siRNAs. The additional blunt-end siRNAs may be needed because the siRNA-RISC complex formation reaction is not the only part of the RNAi pathway that is affected by the presence of the 2-nt overhangs in the siRNA molecules. The reaction in which the bound RISC complex cleaves the mRNA might be affected more due to the difference in the siRNA structures. Further research is required to study this aspect of the RNAi system.
The stochastic simulation framework presented here allows us to predict some quantitative and qualitative aspects of the RNAi system for the two different types of siRNAs used in our study. More importantly, it allows us to build a quantitative framework for studying the length of the gene silencing period and number of siRNA molecules (of both types) required for the same for a cost-potency study. This will require a model to estimate the average number of dsRNA molecules actually entering the cell depending on the dosage interval and amount. The initial predictions from our work are promising, as we plan to build a computational tool for studying the therapeutic effects of the RNAi pathway.
The authors declare that they have no competing interests.
All authors designed, analyzed, implemented and tested the proposed models. Each author contributed equally in writing the paper. All authors read and approved the final manuscript.
This article has been published as part of